483 Nesher Pharmaceuticals (USA) Mar 2000

483 Nesher Pharmaceuticals (USA) Mar 2000

Shirley Berryman FDA, Jeffery Hangartner FDA, Barbara Rogolsky FDA$119.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 03 Mar 2000.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Mar 2000
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart